Ustekinumab-800CW
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ustekinumab-800CW, covering 2025-01-15 to 2025-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis. [Phase 1]